Non-prosthetic surgery in the treatment of erectile dysfunction. A retrospective study of 45 impotent patients in the University of Oulu

Scand J Urol Nephrol. 1998 Feb;32(1):42-6. doi: 10.1080/003655998750014675.

Abstract

The purpose of this retrospective study was to assess the outcomes of the patients with total erectile impotence who have undergone non-prosthetic surgery in our hospital and to make a decision concerning the continuation of this treatment modality. The study series consisted of 45 operated patients, 21 of whom had undergone venous leakage surgery and 24 revascularization of the penis. The follow-up time was at least 12 months. The outcome of venous surgery after 6 months was initially good in 16 patients (76%) but declined in such a way that 12 months after the operation it was good only in 6/21 patients (29%). Despite this, 11/21 patients were capable of intercourse after a prostaglandin E1 injection 1 year from the operation. Altogether 17/21 patients (81%) benefited from venous surgery after 12 months. The outcome of arterial surgery was good in 11/24 patients (46%) 12 months after the operation. A moderate outcome was obtained in another 8/24 patients (33%), who were capable of intercourse after a prostaglandin E1 injection. Minor complications occurred in 20% of the venous surgery patients; 25% of the patients with arterial surgery had complications and half of these were severe, resulting in glans hypervascularization. Our findings indicate that non-prosthetic surgery continues to have an established position in the treatment of severe impotence when all conservative treatment modalities have been used.

MeSH terms

  • Adult
  • Aged
  • Alprostadil / administration & dosage
  • Angiography
  • Erectile Dysfunction / drug therapy
  • Erectile Dysfunction / surgery*
  • Follow-Up Studies
  • Humans
  • Impotence, Vasculogenic / surgery*
  • Male
  • Middle Aged
  • Penis / blood supply*
  • Penis / surgery
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Alprostadil